CHP AUSTRALIA STATEMENT ON PARACETAMOL USE IN PREGNANCY AND AUTISM

Consumer Healthcare Products Australia (CHP Australia) and its members remain committed to safety as the highest priority in the manufacture and responsible use of over-the-counter (OTC) medicines.

Paracetamol is one of the most widely used analgesics, with a long-standing safety record supported by decades of research and everyday use.

Globally, paracetamol remains the only option for pain and fever considered appropriate for use during pregnancy, when taken as directed and under the guidance of a healthcare professional. In Australia, the Therapeutic Goods Administration (TGA) continues to classify paracetamol as a Pregnancy Category A medicine. This is in line with current scientific evidence does not show a causal link between paracetamol use and adverse neurodevelopmental outcomes, including autism.

CHP Australia supports ongoing, independent, high-quality research to further strengthen the evidence base. We also believe it is essential that regulation and public health advice are informed by the best available science, and that Australians are empowered with clear, evidence-based information to support safe and effective self-care.

Over-the-counter paracetamol plays a valuable role in public health, offering convenient access for proven pain relief when used according to directions. Like all medicines, it carries risks if not taken according to dosing instructions. Anyone with questions or concerns about their medicines is encouraged to speak with a healthcare professional, such as your GP or pharmacist, or by calling Health Direct on 1800 022 222.